Table 1: Characteristics of 70 endometrial cancer patients included in the study.
|
Characteristics |
N |
% |
|
Mean age (years) |
61.45 |
|
|
Range |
33-94 |
|
|
Menopausal status |
|
|
|
Premenopausal |
59 |
84.28 |
|
Postmenopausal |
11 |
15.71 |
|
FIGO stage |
|
|
|
I |
45 |
64.28 |
|
II |
5 |
7.14 |
|
III |
10 |
14.28 |
|
IV |
10 |
14.28 |
|
Histological subtype |
|
|
|
Endometrioid |
39 |
55.71 |
|
Serous |
19 |
27.14 |
|
Carcinosarcoma |
12 |
17.14 |
|
Histological differentiation |
|
|
|
Grade 1 |
23 |
32.85 |
|
Grade 2 |
15 |
21.42 |
|
Grade 3 |
32 |
45.71 |
|
Estrogen receptor status |
|
|
|
Yes |
51 |
72.85 |
|
No |
19 |
27.14 |
|
Progesterone receptor status |
|
|
|
Positive |
48 |
68.57 |
|
Negative |
22 |
31.42 |
|
Pelvic lymph node sampling |
|
|
|
Yes |
20 |
28.57 |
|
No |
50 |
71.42 |
|
Status at 1-year follow-up |
|
|
|
Alive |
68 |
97.14 |
|
Dead |
2 |
2.85 |
|
Status at time of follow-up |
|
|
|
Stable |
42 |
60 |
|
Progressive |
28 |
40 |